COVID-19: -

Our Commitment to Client Service & Investor Communications

Sunday Summary

28 Feb 2021 / News

The Sunday Summary provides an overview of Hardman & Co research published over the past seven days, as well as an update on other Hardman happenings.



ICG Enterprise Trust (ICGT)

ICGT’s steps to value-adding portfolio construction

22 February 2021 | Financials


Nova Growth Capital Limited/Sapphire Capital Partners LLP

Nova Cofoundery SEIS & EIS Fund

24 February 2021 | Tax Enhanced


Diurnal Group (DNL)

Attention turning to Chronocort®

25 February 2021 | Pharmaceuticals & Biotechnology


o2h Ventures

The o2h Human Health EIS Knowledge Intensive Fund

25 February 2021 | Tax Enhanced



Hardman Talks | City of London Investment Group (CLIG)

Last week’s webinar is now available to watch again.


Hardman Talks | Milan Radia talks all things tech mega-trends

In a wide-ranging interview, Milan tells us why you can never think too long-term, how to look behind the trend for the companies powering it and why lockdown has caused digital penetration to speed up.


EIS Navigator | Episode 19

Sunil Shah talks about investing in drug development, with o2h Ventures having recently launched the UK’s first Knowledge Intensive Fund focused on this area.